Genetic Testing Company Back After Blow from FDA
Articles Blog

Genetic Testing Company Back After Blow from FDA


I’m Shelby Cullinan with today’s health news.
A genetics company is back in the business of direct-to-consumer genetic tests after
a hiatus prompted by the US FDA. 23andMe, Inc., which calls itself the “leading personal
genetics company,” began offering its Personal Genome Service again Wednesday — nearly
two years after the FDA ordered the company to stop giving consumers genetic health information
without proof of accuracy. The FDA has now given the company the go-ahead to tell customers
whether they carry genes for 36 diseases they could pass down to their children. These diseases
include sickle cell anemia, cystic fibrosis and Tay-Sachs disease. Here’s how the 23andMe
test works: You mail a saliva sample to the company’s lab, and the lab analyzes it and
sends you your results. it costs $199 dollars and also comes with other, nonmedical information
— your future child’s chances of having curly hair or who your ancestors are, for
instance. 23andMe noted that its tests are not meant to tell consumers about their risks
for certain diseases. They’re only meant to tell you whether you carry genes tied to certain
disorders.

Leave a Reply

Your email address will not be published. Required fields are marked *

Back To Top